相关实验视频

Updated: Jun 13, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

在急性心力衰竭中,增长差异化因子-15和N-终端亲BNP与保存的喷射分数

Yoichiro Otaki¹, Tetsu Watanabe¹, Mari Shimizu²

¹Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

ESC heart failure

|February 3, 2025

概括

增长差异化因子15 (GDF15) 和N-终端前脑尿性 (NT-proBNP) 预测心力衰竭与保留喷射分数 (HFpEF) 事件. 综合评估改善了HFpEF患者的风险分层.

科学领域:

心脏病学心脏病学
生物标志物研究生物标志物研究
心脏衰竭研究研究

背景情况:

保存喷射分数 (HFpEF) 的心力衰竭是一个日益严重的临床挑战,死亡率很高.
增长分化因子15 (GDF15) 和N-终端前脑尿素 (NT-proBNP) 的升高与心血管疾病的不良结果有关.

研究的目的:

在被诊断为HFpEF的患者中评估GDF15和NT-proBNP的综合预后值.
评估GDF15超越NT-proBNP在HFpEF中的临床结果上的增量预测能力.

主要方法:

一项前性观察性研究,涉及643名HFpEF患者.
测量了GDF15和NT-proBNP的血清水平.
患者的随访时间中位数为1998天,记录了与HF相关的事件和所有原因的死亡.

主要成果:

无论是GDF15还是NT-proBNP,都与高频相关事件独立相关.
GDF15显著改善了与高频相关事件的预测,证明了增强的重新分类和歧视.
在男性中,GDF15显示出与HF相关的事件和所有死因的预测能力优于NT-proBNP,但在女性中并非如此.
GDF15和NT-proBNP的组合有效地根据不良结果的风险对患者进行了分层.

结论:

血清GDF15提供了对HFpEF患者NT-proBNP的额外预后信息.
GDF15和NT-proBNP的预后性能因性别而异.
GDF15和NT-proBNP是识别高风险HFpEF患者的可行的生物标志物.

关键词:

在GDF15中,GDF15是GDF15中的一个.HFpEF HFpEF 的意思是什么 NT-proBNP 的国家统计数据.临床结果的临床结果.

更多相关视频

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

相关概念视频

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...